Global Psittacosis Treatment Market - Industry Trends and Forecast to 2028

Market Analysis and Insights: Global Psittacosis Treatment Market

Global Psittacosis Treatment market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market is growing at a healthy CAGR of 5.80% in the above-mentioned research forecast period.

Psittacosis, also termed as parrot fever, is a rare infectious disease which is caused due to Chlamydia psittaci. The U.S. has observed less than 10 cases of parrot fever in humans, since 2010, according to the data by Centers for Disease Control and Prevention (CDC). However, these cases go undiagnosed since the symptoms show various kinds of similarity to other illnesses. Not only the parrots are responsible to cause the disease, but other infected wild and pet birds, such as turkey, parakeets, chicken, cockatiels and ducks may also transmit the infection to humans. The severity of the infection may also lead to avian flu. The symptoms reported in humans who contract the infection are pneumonia, flu, fever, chills, muscle, joint pain, multiple organ failure diarrhea and weakness. The Psittacosis is diagnosed by blood and sputum tests. Both these tests can determine which bacteria can cause infection to the patient.  A chest X-ray can display signs of pneumonia. An antibody titer test is performed by a healthcare specialist, to check the antibodies to the bacteria which cause Psittacosis. Changes in the quantity of antibodies can determine whether the patient has been infected with the bacteria or not. The time taken for the individuals to respond is within 24 hours to 72 hours.

Psittacosis are treated with tetracycline and doxycycline. Tetracycline and doxycycline are the two antibiotics which are effective against the disease. Children aged below 10years, are cured with azithromycin. The recovery criteria have proven to be successful. The recovery progress however has been slow in the elderly population. The number of deaths caused due to parrot fever is rare. The disease can be prevented by cleaning the bird cages every day and taking optimum care of the pet birds to avoid them getting infected.

The rising cases of parrot fever, rise in geriatric population, lack of sanitation, increased number of government initiatives for health protection of birds, investment by R&D in pharmaceutical companies, rise in measures to avoid Psittacosis infection and availability of antibiotics for Psittacosis Treatment are predicted to drive the market growth. However, the lack of health remuneration policies, rise in cost, side effects associated with the use of antibiotics and the risk of other diseases linked with Psittacosis infection are expected to hinder the market growth. The rise of emerging markets in developing countries, rise of untapped opportunities, upcoming veterinary clinics, strategic initiatives by the market players are the opportunities which are projected to bolster the market growth. The lack of expertise, use of alternatives other than antibiotics, side effects associated with the antibiotics is the challenges which can tamper the market growth.

This psittacosis treatment market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Global Psittacosis Treatment Market Scope and Market Size

The psittacosis treatment market is segmented on the basis of type, antibiotic type, treatment type, route of administration, mode of purchase and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

• On the basis of type, the psittacosis treatment market is segmented into chlamydia psittaci, chickens, turkeys, pigeons and parakeets.
• On the basis of antibiotic type, the psittacosis treatment market is segmented into tetracycline, chloramphenicol and doxycycline.
• On the basis of treatment type, the psittacosis treatment market is segmented into medication, antibiotic therapy and supportive care.
• On the basis of route of administration, the psittacosis treatment market is segmented into oral, parenteral, intravenous.
• On the basis of mode of purchase, the psittacosis treatment market is segmented into prescription and over the counter.
• On the basis of distribution channel, the psittacosis treatment market has also been segmented into hospital pharmacies, retail pharmacies, online pharmacies and others.

Psittacosis Treatment Market Country Level Analysis

Psittacosis Treatment market is analysed and market size information is provided by country, type, antibiotic type, treatment type, route of administration, mode of purchase and distribution channel as referenced above.

The countries covered in the Psittacosis Treatment market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.

On geographical estimation, North America is expected to hold the largest market share due to the increased cases of parrot infection, increased awareness about the symptoms and prevention of Psittacosis, presence of health policies and affordability of antibiotics. Asia Pacific is also expected to account for the second largest market share due to the rise in point of care diagnostics, increased count of healthcare clinics and veterinary (bird) centers, use of vaccines and untapped opportunities in emerging markets.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Psittacosis Treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Psittacosis Treatment Market Share Analysis

Psittacosis Treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to Psittacosis Treatment market.

The major players covered in the Psittacosis Treatment market are Sanofi, Abbott, Walter Bushnell, ARISTO, Pfizer Inc., JAGSONPAL pharmaceuticals, Dr. Reddy’s Laboratories Ltd, USV Private Limited, Wyeth Pharmaceuticals, Bristol-Myers Squibb Company, GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd, Forest Pharmaceuticals, Inc., BIOCRYST PHARMACEUTICALS, INC., among other domestic and global players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

SKU-60447